FARINGOSEPT, lozenges
Ambazone monohydrate, 10 mg
Faringosept is an effective OTC for inflammation and sore throat with antiseptic action. It treats the infection by stopping the development of pathogenic bacteria, thus inhibiting the development of the disease and accelerating the healing of the irritated throat. A safe and reliable drug for the whole family.
WHAT DOES FARINGOSEPT CONTAIN AND HOW DOES IT WORK?
Faringosept is the only drug in Poland containing Ambazone monohydrate, an active substance that acts:
- antibacterial
- antifungal
- and disinfects
Ambazone1(Ambazone monohydrate) is one of the earliest known and tested antimicrobial substances. The first studies were initiated in 1935, and the drug itself was invented in 1955 to become the basis of all antibacterial sulfonamides.
Ambazone is indicated for acute infections of the mouth and throat such as: pharyngitis, gingivitis, stomatitis, angina and in postoperative care after tonsillectomy.
FARINGOSEPT – PROVEN EFFECTIVENESS
Faringosept inhibits the development of inflammation in the mouth and throat.
WHEN IS FARINGOSEPT RECOMMENDED?
Faringosept is an effective medicine for infections in adults and children, characterized by fever, runny nose, dry cough and sore throat. The medicine is indicated for use:
in acute infections of the mouth and throat such as:
- tonsillitis
- gingivitis
- stomatitis
and also:
- in postoperative care after tonsillectomy
- after tooth extraction
- in the treatment of thrush and fungal infections of the mouth and throat
Faringosept also provides support:
- in antibiotic therapy, because it prevents the development of bacteria and fungi
- in viral infections, especially recurrent ones, which are often accompanied by bacterial superinfection
Faringosept works from the first symptoms of infection!
Faringosept treats the causes of bacterial throat infection, inhibiting the development of inflammation, one of the symptoms of which may be severe pain. The drug is best used immediately, as soon as the first symptoms of the disease appear.
So, if you have the impression that “something is taking over you”, it is time to take Faringosept. If you react quickly, the throat infection will not have a chance to develop.
Faringosept together with antibiotics
Due to its antiseptic effect, the drug is a support in antibiotic therapy used in bacterial infections. Faringosept used together with antibiotics has a local antibacterial effect.
Ambazone monohydrate, contained in Faringosept, works on 92% of pathogenic bacteria strains that may be involved in sore throat. In this case, it works on: streptococci, pneumococci and staphylococci.2,3
However, unlike antibiotics, Faringosept is as effective as with each previous administration, because the risk of developing acquired resistance is negligible.
Faringosept in viral infections
Bacterial infections are very often a complication of viral infections. We then say that a viral infection has superinfected.
The virus weakens the immune system, and then bacteria that are usually harmless to the body can become the cause of another disease, this time on a bacterial background. So if the disease does not go away after a few days, and its symptoms actually intensify, it may mean that a bacterial attack has occurred. Therefore, even with an “ordinary” cold, it is worth using Faringosept as a support.
Remember, it is important to monitor the symptoms and, if necessary, consult a doctor, especially if the symptoms intensify or persist for a longer period of time.
Make sure to take care of rest, proper diet and immune support at every opportunity, especially if you feel weak!
Worth to know!
Faringosept is characterized by very high effectiveness in bacterial infections such as tonsillitis or infections caused by sudden changes in temperature, e.g. air conditioning, ice cream, cold drinks, etc.
WHY TO USE FARINGOSEPT? 3
Faringosept is EFFECTIVE:
- INHIBITS THE DEVELOPMENT OF INFECTIONS, thanks to the content of Ambazone monohydrate, which disinfects the throat, has antibacterial and antifungal effects.
- HAS A WIDE SPECTRUM OF INDICATIONS. Faringosept is used in acute infections of the oral cavity and throat: tonsillitis, gingivitis, stomatitis, as well as after surgery to remove the tonsils and after tooth extraction.
- WORKS FROM THE FIRST SYMPTOMS of infection. Added to therapy, IT WORKS ON ITS CAUSE, not just the symptoms.
- The beneficial therapeutic effect is additionally enhanced by the form of the drug – a lozenge. When sucking Faringosept, saliva is produced, which additionally has a protective and soothing effect on the throat.
Faringosept is SAFE
- Gluten-free
- Does not disturb physiological intestinal flora
- Works locally
- Does not disturb concentration
- Does not interact with other drugs
Faringosept is TASTY and NATURAL
- Does not contain preservatives
- Does not contain artificial colors and flavors
- Has a cocoa-chocolate flavor, thanks to the content of 100% natural cocoa
Worth to know!
When using Faringosept, the risk of developing acquired resistance is practically negligible. This means that each time the patient takes Faringosept (Ambazone monohydrate), the drug is as effective as the previous time it was administered.
WHO IS FARINGOSEPT FOR?3
Faringosept is OTC for the whole family. Especially for adults, seniors and children. Faringosept has no lower age limit for use. Practically, thanks to its high safety profile, it can be used in very young children who can handle a lozenge. In young children, the medicine should be used under adult supervision.
HOW TO TAKE FARINGOSEPT?
Recommended dose to administer:
3-5 tablets per day, for 3-4 days
Instructions for use:
- Suck 3 to 5 tablets per day, for 3 to 4 days
- It is best to suck slowly until they dissolve in the mouth
- Do not swallow the tablets
- Take 15-30 minutes after a meal
- It is best not to eat or drink for 2-3 hours after taking the medicine
Available size of packs: 10 and 20 lozenges








Literature:
1. Bacteriologia, Virusologia, Parazitologia, Epidemiologia, Vol 52, nr. 1-2, 2007
2. Negut M., Fulga J., Davila C. „Study on the Sensitivity to Faringosept of Microbes in Pharyngeal Isolates from Patients with Acute Infection of the Upper Respiratory Tract”, University of Medicine and Pharmacy, Bucharest; 2006-2007
3. According with the SPC of 31.12.2003.